The DOI matches its Crossref record.
RAPID COMMUNICATION: Predominant Intracellular Overexpression of the Na+/I- Symporter (NIS) in a Large Sampling of Thyroid Cancer Cases
Open accessAbstract
Here we report the analysis of the Na(+)/I(-) symporter (NIS) protein expression in 57 thyroid cancer samples by immunohistochemistry with high-affinity anti-NIS Abs. As many as 70% of these samples exhibited increased NIS expression with respect to the normal surrounding thyroid tissue. Most significantly, NIS was located in these samples either in both the plasma membrane and intracellular compartments simultaneously, or exclusively in intracellular compartments. This suggests that NIS is clearly expressed or even overexpressed in most thyroid cancer cells, but malignant transformation in some of these cells interferes either with the proper targeting of NIS to the plasma membrane, or with the mechanisms that retain NIS in the plasma membrane after it has been targeted. The results further indicate that, in addition to indicating NIS expression in cases where it is absent (approximately 30%), improvements in (131)I radioablation therapy might result from promoting targeting of NIS to the plasma membrane in the majority (approximately 70%) of thyroid cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Sodium/Iodide Symporter (NIS): Characterization, Regulation, and Medical Significance
Dohán, O., De la Vieja, A., Paroder, V., Riedel, C., Artani, M., Reed, M., Ginter, C. S., & Carrasco, N. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0029 · Cited by 861
Self-citationRiesco-Eizaguirre, G., Gutiérrez-Martínez, P., García-Cabezas, M. A., Nistal, M., & Santisteban, P. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.01119 · Cited by 376
Thyroid hormone biosynthesis and release
Carvalho, D. P., & Dupuy, C. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.038 · Cited by 346
The Na+/I− Symporter (NIS): Mechanism and Medical Impact
Portulano, C., Paroder-Belenitsky, M., & Carrasco, N. (2014) · Endocrine Reviews · doi:10.1210/er.2012-1036 · Cited by 319
Molecular Pathogenesis of Euthyroid and Toxic Multinodular Goiter
Krohn, K., Führer, D., Bayer, Y., Eszlinger, M., Brauer, V., Neumann, S., Paschke, R., & Führer-Sakel, D. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0005 · Cited by 318
Wapnir, I. L., van de Rijn, M., Nowels, K., Amenta, P. S., Walton, K., Montgomery, K., Greco, R. S., Dohán, O., & Carrasco, N. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021544 · Cited by 303
Riesco-Eizaguirre, G., Rodríguez, I., De la Vieja, A., Costamagna, E., Carrasco, N., Nistal, M., & Santisteban, P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1248 · Cited by 265
Self-citationOh, J. M., & Ahn, B.-C. (2021) · Theranostics · doi:10.7150/thno.57689 · Cited by 163
Rapid regulation of thyroid sodium–iodide symporter activity by thyrotrophin and iodine
Ferreira, A. C. F., Lima, L. P., Araújo, R. L., Müller, G., Rocha, R. P., Rosenthal, D., & Carvalho, D. P. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.05643 · Cited by 86
“Thus iodide transport is secondary to the sodium gradient formed by the Na+/K+-ATPase also present in the basolateral membrane of thyrocytes (Dai et al. 1996, Smanik et al. 1996, Eskandari et al. 1997, Dohan et al. 2001, 2003, Van Sande et al. 2003).”
BackgroundThe importance of sodium/iodide symporter (NIS) for thyroid cancer management
Carvalho, D. P., & Ferreira, A. C. F. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000500004 · Cited by 53
Metadata
- Authors
- Dohan, O.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2001-06-01
- Volume
- 86
- Issue
- 6
- Pages
- 2697-2700
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2155180139
- Cited by
- 188
- References
- 0
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.